Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 318


Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings.

Buttram ME, Kurtz SP, Dart RC, Margolin ZR.

Pharmacoepidemiol Drug Saf. 2017 May 10. doi: 10.1002/pds.4230. [Epub ahead of print]


Measures that identify prescription medication misuse, abuse, and related events in clinical trials: ACTTION critique and recommended considerations.

Smith SM, Jones JK, Katz NP, Roland CL, Setnik B, Trudeau JJ, Wright S, Burke LB, Comer SD, Dart RC, Dionne R, Haddox JD, Jaffe JH, Kopecky EA, Martell BA, Montoya ID, Stanton M, Wasan AD, Turk DC, Dworkin RH.

J Pain. 2017 May 4. pii: S1526-5900(17)30569-2. doi: 10.1016/j.jpain.2017.03.015. [Epub ahead of print]


Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.

Dart RJ, Samaan MA, Powell N, Irving PM.

Clin Exp Gastroenterol. 2017 Mar 3;10:57-66. doi: 10.2147/CEG.S110547. eCollection 2017. Review.


Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration.

Green JL, Bucher Bartelson B, Le Lait MC, Roland CL, Masters ET, Mardekian J, Bailey JE, Dart RC.

Drug Alcohol Depend. 2017 Jun 1;175:140-145. doi: 10.1016/j.drugalcdep.2017.01.039. Epub 2017 Mar 28.


(144) Routes of administration of tapentadol products as reported to poison centers.

Severtson S, Bucher Bartelson B, Green J, Dart R.

J Pain. 2016 Apr;17(4S):S12. doi: 10.1016/j.jpain.2016.01.047. Epub 2016 Mar 24. No abstract available.


Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States.

Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC.

PLoS One. 2016 Dec 9;11(12):e0167499. doi: 10.1371/journal.pone.0167499. eCollection 2016.


Serum Acetaminophen Protein Adduct Concentrations in Pediatric Emergency Department Patients.

Heard K, Anderson V, Dart RC, Kile D, Lavonas EJ, Green JL.

J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):533-535. doi: 10.1097/MPG.0000000000001459.


Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.

Severtson SG, Ellis MS, Kurtz SP, Rosenblum A, Cicero TJ, Parrino MW, Gilbert MK, Buttram ME, Dasgupta N, BucherBartelson B, Green JL, Dart RC.

Drug Alcohol Depend. 2016 Nov 1;168:219-229. doi: 10.1016/j.drugalcdep.2016.09.018. Epub 2016 Oct 3.


Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments.

Di Marco Barros R, Roberts NA, Dart RJ, Vantourout P, Jandke A, Nussbaumer O, Deban L, Cipolat S, Hart R, Iannitto ML, Laing A, Spencer-Dene B, East P, Gibbons D, Irving PM, Pereira P, Steinhoff U, Hayday A.

Cell. 2016 Sep 22;167(1):203-218.e17. doi: 10.1016/j.cell.2016.08.030. Epub 2016 Sep 15.


Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individuals.

Teixeira PL, Wei WQ, Cronin RM, Mo H, VanHouten JP, Carroll RJ, LaRose E, Bastarache LA, Rosenbloom ST, Edwards TL, Roden DM, Lasko TA, Dart RA, Nikolai AM, Peissig PL, Denny JC.

J Am Med Inform Assoc. 2017 Jan;24(1):162-171. doi: 10.1093/jamia/ocw071. Epub 2016 Aug 7.


Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association.

Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR, Dart RA, Newton-Cheh CH, Sacks FM, Laffer CL; American Heart Association Professional and Public Education Committee of the Council on Hypertension; Council on Functional Genomics and Translational Biology; and Stroke Council..

Hypertension. 2016 Sep;68(3):e7-e46. doi: 10.1161/HYP.0000000000000047. Epub 2016 Jul 21. No abstract available. Erratum in: Hypertension. 2016 Oct;68(4):e62.


The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.

Coplan PM, Chilcoat HD, Butler SF, Sellers EM, Kadakia A, Harikrishnan V, Haddox JD, Dart RC.

Clin Pharmacol Ther. 2016 Sep;100(3):275-86. doi: 10.1002/cpt.390. Epub 2016 Jun 22. Erratum in: Clin Pharmacol Ther. 2017 Apr;101(4):541.


Accuracy of the Structured Medication History Assessment Tool (MedHAT) Compared with Recorded Real-Time Medication Use.

Heard K, Anderson VE, Dart RC, Green JL.

Pharmacotherapy. 2016 May;36(5):496-504. doi: 10.1002/phar.1750. Epub 2016 May 2.


Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System.

Wiegand TJ, Le Lait MC, Bartelson BB, Dart RC, Green JL.

J Pain. 2016 Jun;17(6):745-52. doi: 10.1016/j.jpain.2016.02.015. Epub 2016 Mar 18.


Outcomes of Patients With Premature Discontinuation of the 21-h Intravenous N-Acetylcysteine Protocol After Acute Acetaminophen Overdose.

Lucyk SN, Yarema MC, Sivilotti ML, Johnson DW, Nettel-Aguirre A, Victorino C, Bailey B, Dart RC, Heard K, Spyker DA, Rumack BH.

J Emerg Med. 2016 Apr;50(4):629-37. doi: 10.1016/j.jemermed.2015.12.004. Epub 2016 Feb 15.


Diversion and Illicit Sale of Extended Release Tapentadol in the United States.

Dart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, Brownstein JS, Burke JJ, Kurtz SP, Dasgupta N.

Pain Med. 2016 Aug;17(8):1490-6. doi: 10.1093/pm/pnv032. Epub 2015 Dec 14.


Acute hepatotoxicity associated with therapeutic doses of intravenous acetaminophen.

Seifert SA, Kovnat D, Anderson VE, Green JL, Dart RC, Heard KJ.

Clin Toxicol (Phila). 2016 Mar;54(3):282-5. doi: 10.3109/15563650.2015.1134798. Epub 2016 Jan 14.


The prescription paradox of acetaminophen safety.

Dart RC, Green JL.

Pharmacoepidemiol Drug Saf. 2016 May;25(5):599-601. doi: 10.1002/pds.3930. Epub 2015 Dec 29. No abstract available.


Prescription opioid exposures and adverse outcomes among older adults.

West NA, Dart RC.

Pharmacoepidemiol Drug Saf. 2016 May;25(5):539-44. doi: 10.1002/pds.3934. Epub 2015 Dec 13.


Paracetamol (acetaminophen) protein adduct concentrations during therapeutic dosing.

Heard K, Green JL, Anderson V, Bucher-Bartelson B, Dart RC.

Br J Clin Pharmacol. 2016 Mar;81(3):562-8. doi: 10.1111/bcp.12831. Epub 2016 Jan 14.

Supplemental Content

Loading ...
Support Center